Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association study.
Clarelli F, Corona A, Pääkkönen K, Sorosina M, Zollo A, Piehl F, Olsson T, Stridh P, Jagodic M, Hemmer B, Gasperi C, Harroud A, Shchetynsky K, Mingione A, Mascia E, Misra K, Giordano A, Mazzieri MLT, Priori A, Saarela J, Kockum I, Filippi M, Esposito F, Boneschi FGM. Clarelli F, et al. Among authors: mascia e. J Neurol. 2024 Nov;271(11):7250-7263. doi: 10.1007/s00415-024-12608-6. Epub 2024 Sep 12. J Neurol. 2024. PMID: 39264442 Free PMC article.
Vitamin D affects the risk of disease activity in multiple sclerosis.
Giordano A, Clarelli F, Pignolet B, Mascia E, Sorosina M, Misra K, Ferrè L, Bucciarelli F, Manouchehrinia A, Moiola L, Martinelli V, Rocca MA, Liblau R, Filippi M, Esposito F. Giordano A, et al. Among authors: mascia e. J Neurol Neurosurg Psychiatry. 2024 Jul 14:jnnp-2024-334062. doi: 10.1136/jnnp-2024-334062. Online ahead of print. J Neurol Neurosurg Psychiatry. 2024. PMID: 39004505
Genetic Contribution to Medium-Term Disease Activity in Multiple Sclerosis.
Mascia E, Nale V, Ferrè L, Sorosina M, Clarelli F, Chiodi A, Santoro S, Giordano A, Misra K, Cannizzaro M, Moiola L, Martinelli V, Milanesi L, Filippi M, Mosca E, Esposito F. Mascia E, et al. Mol Neurobiol. 2024 Jun 8. doi: 10.1007/s12035-024-04264-8. Online ahead of print. Mol Neurobiol. 2024. PMID: 38850349
Risk HLA Variants Affect the T-Cell Repertoire in Multiple Sclerosis.
Sorosina M, Santoro S, Ferrè L, Mascia E, Clarelli F, Giordano A, Cannizzaro M, Lucia M, Martinelli V, Filippi M, Esposito F. Sorosina M, et al. Among authors: mascia e. Neurol Neuroimmunol Neuroinflamm. 2023 Feb 15;10(3):e200093. doi: 10.1212/NXI.0000000000200093. Print 2023 May. Neurol Neuroimmunol Neuroinflamm. 2023. PMID: 36792371 Free PMC article.
Combining Clinical and Genetic Data to Predict Response to Fingolimod Treatment in Relapsing Remitting Multiple Sclerosis Patients: A Precision Medicine Approach.
Ferrè L, Clarelli F, Pignolet B, Mascia E, Frasca M, Santoro S, Sorosina M, Bucciarelli F, Moiola L, Martinelli V, Comi G, Liblau R, Filippi M, Valentini G, Esposito F. Ferrè L, et al. Among authors: mascia e. J Pers Med. 2023 Jan 6;13(1):122. doi: 10.3390/jpm13010122. J Pers Med. 2023. PMID: 36675783 Free PMC article.
A Whole-Genome Sequencing Study Implicates GRAMD1B in Multiple Sclerosis Susceptibility.
Esposito F, Osiceanu AM, Sorosina M, Ottoboni L, Bollman B, Santoro S, Bettegazzi B, Zauli A, Clarelli F, Mascia E, Calabria A, Zacchetti D, Capra R, Ferrari M, Provero P, Lazarevic D, Cittaro D, Carrera P, Patsopoulos N, Toniolo D, Sadovnick AD, Martino G, De Jager PL, Comi G, Stupka E, Vilariño-Güell C, Piccio L, Martinelli Boneschi F. Esposito F, et al. Among authors: mascia e. Genes (Basel). 2022 Dec 16;13(12):2392. doi: 10.3390/genes13122392. Genes (Basel). 2022. PMID: 36553660 Free PMC article.
44 results